MedCap AB (61MA) Stock Statistics & Valuation Metrics
Total Valuation
MedCap AB has a market cap or net worth of EUR 760.84M. The enterprise value is EUR 8.01B.
- Market Cap
- EUR 760.84M
- Enterprise Value
- EUR 8.01B
Share Statistics
MedCap AB has 15,080,753 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 15,080,753
- Owned by Insiders
- ―
- Owned by Institutions
- 3.22%
Financial Efficiency
MedCap AB’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 10.35%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 10.35%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 3.26M
- Profits Per Employee
- 339.72K
- Employee Count
- 647
- Asset Turnover
- 0.81
- Inventory Turnover
- 6.58
Valuation Ratios
The current PE Ratio of MedCap AB is 30.25. MedCap AB’s PEG ratio is 0.78.
- PE Ratio
- 30.25
- PS Ratio
- 3.57
- PB Ratio
- 4.85
- Price to FCF
- 22.11
- Price to Operating Cash Flow
- 19.62
- PEG Ratio
- 0.78
Income Statement
In the last 12 months, MedCap AB had revenue of 2.11B and earned 219.80M in profits. Earnings per share was 14.67.
- Revenue
- 2.11B
- Gross Profit
- 321.00M
- Operating Income
- 300.20M
- Pretax Income
- 289.00M
- Net Income
- 219.80M
- EBITDA
- 473.80M
- Earnings Per Share (EPS)
- 14.67
Cash Flow
In the last 12 months, operating cash flow was 422.00M and capital expenditures -47.40M, giving a free cash flow of 374.60M billion.
- Operating Cash Flow
- 422.00M
- Free Cash Flow
- 374.60M
- Free Cash Flow per Share
- 25.01
Dividends & Yields
MedCap AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.52%
- Earnings Yield
- 3.31%
Stock Price Statistics
- Beta
- 0.28
- 52-Week Price Change
- -11.73%
- 50-Day Moving Average
- 47.77
- 200-Day Moving Average
- 46.73
- Relative Strength Index (RSI)
- 63.25
- Average Volume (3m)
- 6
Important Dates
MedCap AB upcoming earnings date is Feb 05, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 23, 2026
- Next Earnings Date
- Feb 05, 2027
- Ex-Dividend Date
- ―
Financial Position
MedCap AB as a current ratio of 2.01, with Debt / Equity ratio of 33.26%
- Current Ratio
- 2.01
- Quick Ratio
- 1.46
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- 0.24
- Interest Coverage Ratio
- 9.53
Taxes
In the past 12 months, MedCap AB has paid 68.30M in taxes.
- Income Tax
- 68.30M
- Effective Tax Rate
- 0.24
Enterprise Valuation
MedCap AB EV to EBITDA ratio is 15.14, with an EV/FCF ratio of 22.55.
- EV to Sales
- 3.64
- EV to EBITDA
- 15.14
- EV to Free Cash Flow
- 22.55
- EV to Operating Cash Flow
- 20.02
Balance Sheet
MedCap AB has EUR 272.80M in cash and marketable securities with EUR 437.70M in debt, giving a net cash position of -EUR 164.90M billion.
- Cash & Marketable Securities
- EUR 272.80M
- Total Debt
- EUR 437.70M
- Net Cash
- -EUR 164.90M
- Net Cash Per Share
- -EUR 10.93
- Tangible Book Value Per Share
- EUR 21.05
Margins
Gross margin is 38.01%, with operating margin of 15.50%, and net profit margin of 11.82%.
- Gross Margin
- 38.01%
- Operating Margin
- 15.50%
- Pretax Margin
- 15.18%
- Net Profit Margin
- 11.82%
- EBITDA Margin
- 24.04%
- EBIT Margin
- 15.98%
Analyst Forecast
The average price target for MedCap AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 19.59%
- EPS Growth Forecast
- 42.34%
